GPR35, ally of the anti-ischemic ATPIF1-ATP synthase interaction
- PMID: 36195494
- DOI: 10.1016/j.tips.2022.09.003
GPR35, ally of the anti-ischemic ATPIF1-ATP synthase interaction
Abstract
Mitochondrial ATP synthase synthesizes ATP for cellular functions; however, under various conditions, including ischemia, it hydrolyzes ATP, primarily to re-energize the mitochondria. ATP synthase inhibitory factor 1 (ATPIF1) inhibits hydrolysis of ATP by ATP synthase. Wyant and colleagues recently demonstrated that G-protein-coupled receptor 35 (GPR35) is involved in this process. This finding provides an additional framework for the novel discovery of potential therapeutic molecules against ischemia/reperfusion (I/R) injury.
Keywords: ATP inhibitory factor 1; ATP synthase; G-protein-coupled receptor 35; anti-ischemic interaction; kynurenic acid; mitochondria.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests None declared by author.
Comment on
-
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.Science. 2022 Aug 5;377(6606):621-629. doi: 10.1126/science.abm1638. Epub 2022 Aug 4. Science. 2022. PMID: 35926043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources